Mifepristone Helped Control Diabetes in Those With Hypercortisolism

By News Health
7 hours Ago

(MedPage Today) — CHICAGO — Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and hypercortisolism, a randomized placebo-controlled trial showed.
Among 136 patients, the least squares mean…

Source link : https://www.medpagetoday.com/meetingcoverage/ada/116204

Author :

Publish date : 2025-06-23 20:15:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Datroway Gains Second FDA Nod With NSCLC Approval

AID Systems Need Upgrades for Premenopausal Glucose Control

Metabolic Syndrome and Psoriatic Arthritis: Common but Unwanted Bedfellows

CMS Tightens Reins on Obamacare Access

Ozempic Shows Benefit in Type 1 Diabetes Patients With Obesity

Test Predicts Cognitive Decline in Parkinson's Disease